RevMAb Biosciences USA, Inc.

RevMAb Biosciences USA, Inc. is a South San Francisco based biotechnology company founded in 2012. They specialize in the development of Goat and Rabbit monoclonal antibodies using a revolutionary technology that eliminates the need for cell fusion and hybridoma generation. Their mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis through the provision of superior monoclonal antibodies. Their last recorded investment was a $2.34M Venture Round on 15 February 2018. As a startup focusing on Biotechnology and Health Care, RevMAb Biosciences USA, Inc. presents a compelling opportunity in the field of antibody manufacturing and supply. With their innovative approach and commitment to driving advancements in biomedical research, they are poised for significant growth and impact in the health care industry.